skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. EXE: please comment on 4th q results and outlook. [Extendicare Inc.]
You can view 0 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: please comment on 4th q results and outlook. Stock seems cheap.
Asked by Murray on February 28, 2025
5i Research Answer:

EPS was 86c, vs estimates of 79c; revenue of $1.466B beat estimates of $1.43B. EBITDA of $144.5M beat estimates by 5%. Revenue rose 12%. EBITDA rose 39%. Cash flow per share (adjusted) was 32c vs 21c the prior year. The dividend was raised 5%. Occupancy rose slightly to 98%. Payout ratio dropped below 50%. These were very solid results.